EMMA offering history
Every offering-related filing in Emmaus Life Sciences, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,002 filings back to Sep 2, 2009.
| Date | Filing | What it means | |
|---|---|---|---|
| Dec 22, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 26, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 20, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 7, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 19, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 16, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 3, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 25, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 14, 2019 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 11, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 24, 2019 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 26, 2018 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 21, 2018 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 14, 2018 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Sep 26, 2018 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 29, 2018 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 8, 2018 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Jun 8, 2018 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 8, 2018 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 8, 2018 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 22, 2018 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 18, 2018 | RW → | WITHDRAWN | Registration withdrawn |
| May 18, 2018 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| May 18, 2018 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 18, 2018 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Apr 3, 2018 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 23, 2018 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Feb 23, 2018 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jul 17, 2017 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jul 13, 2017 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jul 13, 2017 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jul 13, 2017 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 3, 2017 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jun 30, 2017 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jun 19, 2017 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jun 16, 2017 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jun 2, 2017 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Mar 31, 2017 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Mar 24, 2017 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 16, 2017 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
EMMA offering FAQ
When did EMMA last execute an offering?
Per SEC filings, Emmaus Life Sciences, Inc.'s most recent priced offering document is a 8-K filed 2025-12-22. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did EMMA last announce or register an offering?
The most recent registration is a S-1 filed 2018-12-14. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.